ES2172485T1 - Composiciones oftalmicas en forma de gel acuoso. - Google Patents

Composiciones oftalmicas en forma de gel acuoso.

Info

Publication number
ES2172485T1
ES2172485T1 ES00945849T ES00945849T ES2172485T1 ES 2172485 T1 ES2172485 T1 ES 2172485T1 ES 00945849 T ES00945849 T ES 00945849T ES 00945849 T ES00945849 T ES 00945849T ES 2172485 T1 ES2172485 T1 ES 2172485T1
Authority
ES
Spain
Prior art keywords
ophthalmic compositions
water gel
cogelifying
cosolubilizing
cps
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES00945849T
Other languages
English (en)
Other versions
ES2172485T3 (es
Inventor
Marco Sanso'
Renato Sebben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FARMILA FARMA MILANO
Pfizer Italia SRL
Original Assignee
FARMILA FARMA MILANO
Farmaceutici Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FARMILA FARMA MILANO, Farmaceutici Italia SpA filed Critical FARMILA FARMA MILANO
Publication of ES2172485T1 publication Critical patent/ES2172485T1/es
Application granted granted Critical
Publication of ES2172485T3 publication Critical patent/ES2172485T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composiciones oftálmicas en forma de gel acuoso con un intervalo de viscosidad entre 400 y 800 mPa.s (cps) que comprenden: - un principio activo; - un agente gelificante y al menos dos agentes cosolubilizantes/cogelificantes, uno de los cuales es un derivado polietoxilado de aceite de ricino hidrogenado.
ES00945849T 1999-07-01 2000-06-29 Composiciones oftalmicas en forma de geles acuosos. Expired - Lifetime ES2172485T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001453A ITMI991453A1 (it) 1999-07-01 1999-07-01 Composizioni oftalmiche in forma di gel acquosi
ITMI991453 1999-07-01

Publications (2)

Publication Number Publication Date
ES2172485T1 true ES2172485T1 (es) 2002-10-01
ES2172485T3 ES2172485T3 (es) 2004-02-01

Family

ID=11383262

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00945849T Expired - Lifetime ES2172485T3 (es) 1999-07-01 2000-06-29 Composiciones oftalmicas en forma de geles acuosos.

Country Status (10)

Country Link
EP (1) EP1189595B1 (es)
AT (1) ATE240094T1 (es)
AU (1) AU5980200A (es)
DE (2) DE60002719T2 (es)
DK (1) DK1189595T3 (es)
ES (1) ES2172485T3 (es)
HK (1) HK1042437B (es)
IT (1) ITMI991453A1 (es)
PT (1) PT1189595E (es)
WO (1) WO2001001959A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7527807B2 (en) 2000-06-21 2009-05-05 Cubist Pharmaceuticals, Inc. Compositions and methods for increasing the oral absorption of antimicrobials
US7045121B2 (en) * 2001-12-14 2006-05-16 Allergan, Inc. Ophthalmic compositions for lubricating eyes and methods for making and using same
AU2003254566A1 (en) * 2002-07-23 2004-02-09 Novartis Ag Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
EP2113246B1 (en) 2003-08-07 2016-06-22 Allergan, Inc. Compositions for delivery of therapeutics into the eyes and methods for making and using the same
CN100360132C (zh) * 2003-08-25 2008-01-09 成都三明药物研究所 一种用于眼部的抗病毒药物组合物及其制备方法
US7858115B2 (en) 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US8968781B2 (en) 2005-04-29 2015-03-03 Cubist Pharmaceuticals, Inc. Therapeutic compositions
US9192571B2 (en) 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
US7842714B2 (en) 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
JP2010104632A (ja) * 2008-10-31 2010-05-13 Hoya Corp ゲル化能を有する眼科用組成物
PL2586426T3 (pl) 2009-12-03 2016-01-29 Alcon Res Ltd Zawiesiny zawierające nanocząsteczkowe polimery karboksywinylowe
ITMI20122002A1 (it) * 2012-11-26 2014-05-27 Farmacologico Milanese Srl Lab Preparazioni farmaceutiche liquide stabilizzate
WO2017180851A1 (en) 2016-04-13 2017-10-19 Avedro, Inc. Systems and methods for delivering drugs to an eye
CN115969776B (zh) * 2023-02-06 2023-08-29 湖南九典制药股份有限公司 氟比洛芬钠凝胶组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947573A (en) * 1969-12-01 1976-03-30 Burton, Parsons And Company, Inc. Opthalmic solution
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
SE8005321L (sv) * 1979-07-31 1981-02-01 Lion Corp Oral komposition
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
FR2699081B1 (fr) * 1992-12-11 1995-04-07 Lvmh Rech Utilisation d'un extrait de Simaba pour l'atténuation des taches pigmentaires cutanées ou pour renforcer la fonction protectrice de la peau, ou pour la préparation d'un milieu de culture de cellules de peau, et composition ainsi obtenue.
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol

Also Published As

Publication number Publication date
EP1189595B1 (en) 2003-05-14
DE60002719D1 (de) 2003-06-18
ITMI991453A1 (it) 2001-01-01
DE60002719T2 (de) 2003-10-09
ITMI991453A0 (it) 1999-07-01
DK1189595T3 (da) 2003-09-15
HK1042437B (zh) 2003-08-22
WO2001001959A1 (en) 2001-01-11
AU5980200A (en) 2001-01-22
EP1189595A1 (en) 2002-03-27
DE1189595T1 (de) 2002-10-17
ATE240094T1 (de) 2003-05-15
ES2172485T3 (es) 2004-02-01
HK1042437A1 (en) 2002-08-16
PT1189595E (pt) 2003-08-29

Similar Documents

Publication Publication Date Title
ES2172485T1 (es) Composiciones oftalmicas en forma de gel acuoso.
ES2151968T3 (es) Composiciones hemorroidales y metodo de utilizacion.
ES2196160T3 (es) Uso de una combinacion de tensioactivos, agentes quelantes y aceites esenciales para desinfeccion efectiva.
BR0013255A (pt) Agente substitutivo lacrimal
DK0781547T3 (da) Ophthalmisk formulering baseret på natriumhyaluronat til anvendelse i øjen-kirugi
ATE238813T1 (de) Wirkstoffformulierungen mit verzögerter freisetzung
PT946143E (pt) Composicao gelificada a base de nitro-imidazole.
BR0100652A (pt) Sistema hidráulico
BG101660A (en) Galenic form of vaginal application as a local contraceprive and/or for protection against diseases carryed by sex and/or aids
MX9405006A (es) Solucion oftalmica para lagrimas artificiales.
ES2123323T3 (es) Asociacion de un compuesto con actividad antimicrobiana (por ejemplo lipoaminoacido n,n-octanoilglicina) y de un monoalquileter de glicerol y su uso como agente antimicrobiano.
AR023715A1 (es) Composicion farmaceutica para un sujeto que necesita una elevacion del contenido de nad intracelular, y el uso de la misma para la manufactura de unmedicamento para aumentar las respuestas celulares protectoras al stress genotoxico en la piel
AR031145A1 (es) Articulo absorbente que mejora la funcion de barrera de la piel, un metodo para aplicar una composicion a una superficie de dicho articulo absorbente, la composicion que comprende dicho metodo y metodo para incrementar la funcion de barrera de la piel sobre dicha superficie
CO5150154A1 (es) Composicion de sustrato y metodo para usarlo para el secuestro de irritantes de la piel
DK0527801T3 (da) Thiophensulfonamider, der er anvendelige som carboanhydraseinhibitorer
NO971496L (no) Asfalt-slippmiddel og fremgangsmåte for anvendelse
CL2004000931A1 (es) Pelicula consumible adaptada para adherirse y disolverse en la cavidad bucal que comprende un almidon modificado y un agente farmaceuticamente activo.
BR0208197A (pt) Preservativo com composição eretogênica
ES2111547T3 (es) Comprimido de liberacion prolongada.
ES2091001T3 (es) Capsula que contiene un componente susceptible de degradacion y un polimero compuesto.
CO5001019A1 (es) Composicion emulsionable para la represion de insectos, que se deriva del tipo de fenilpirazoles sustituidos en posi- cion 1, y no favorecen la formacion de cristales
ES2159354T3 (es) Preparado en gel oftalmologico esteril aplicable en gotas, y procedimiento para su obtencion.
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
FI932453A (fi) Geltypkompositioner med foerbaettrad fettkontroll
CO5261494A1 (es) Composiciones farmaceuticas acuosas e hipotonicas de ciclesonida que presentan absorcion nasal mejorada